Hepatitis E virus antibodies in patients with chronic liver disease

Emerg Infect Dis. 2009 Mar;15(3):479-81. doi: 10.3201/eid1503.080740.

Abstract

In the United States, the seroprevalence rate for hepatitis E virus (HEV) is approximately 20%. This study examined HEV seroprevalence in persons with and without chronic liver disease. Our data indicate that HEV seropositivity is high in patients with chronic liver disease and that HEV seroprevalence increases significantly with age.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Chronic Disease
  • Cross-Sectional Studies
  • Female
  • Hepatitis Antibodies / blood*
  • Hepatitis E / epidemiology*
  • Hepatitis E / virology
  • Hepatitis E virus / immunology*
  • Humans
  • Liver Diseases / epidemiology*
  • Liver Diseases / immunology
  • Liver Diseases / virology
  • Male
  • Middle Aged
  • Ohio / epidemiology
  • Risk Factors
  • Seroepidemiologic Studies

Substances

  • Hepatitis Antibodies